FDA Authorizes Pfizer Vaccine for Emergency Use in Adolescents (video)

Today, the U.S. Food and Drug Administration expanded the emergency use authorization for the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 to include adolescents 12 through 15 years of age.

The FDA amended the EUA originally issued on Dec. 11, 2020 for administration in individuals 16 years of age and older.

โ€œThe FDAโ€™s expansion of the emergency use authorization for the Pfizer-BioNTech COVID-19 Vaccine to include adolescents 12 through 15 years of age is a significant step in the fight against the COVID-19 pandemic,โ€ said Acting FDA Commissioner Janet Woodcock, M.D.

โ€œTodayโ€™s action allows for a younger population to be protected from COVID-19, bringing us closer to returning to a sense of normalcy and to ending the pandemic.

Parents and guardians can rest assured that the agency undertook a rigorous and thorough review of all available data, as we have with all of our COVID-19 vaccine emergency use authorizations.โ€

FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Adolescents in Another Important Action in Fight Against Pandemic

FDA Statement on Vaccines and Related Biological Products Advisory Committee Meeting

What Is An Emergency Kit?

0 0 votes
Article Rating
,

1 Comment
Oldest
Newest
Inline Feedbacks
View all comments
%d